Andson Biotech
Andson Biotech built, from the ground up, process analytical technologies (PATs) to fill the void of existing sensor technologies for advanced biomanufacturing.
About the Company
About Andson: (TL;DR video about us: https://youtu.be/wMyAikoQkXE)
Andson Biotech is developing a microfluidic platform enabling rapid sample cleanup for mass spectrometry applications. Mass spectrometry is a gold-standard chemical analysis tool, but it remains limited in utility due to the complex workflows associated with going from raw sample to analysis. Our flagship product, the DynaCHIP, enables simple, on-demand mass spectrometric analysis with easy-to-use interfaces that democratize mass spectrometry from lab to market.
Andson Biotech was spun out of Georgia Tech and is supported by Y Combinator and Merck Digital Sciences Studio. We are a seed-stage startup, so every role has the chance for growth.
Founders
Mason is the co-founder and CEO of Andson Biotech, an academic spinout based on Mason's research at the Georgia Institute of Technology. At Andson, Mason is driving the company's mission to develop novel methodologies for advanced biomanufacturing discovery and monitoring. Mason is formally trained as a mechanical engineer with a BS from the University of South Florida ('14) and an MS and PhD from Georgia Tech ('17, '20).
Open Positions at Andson Biotech (3 Jobs)
Ready to start your space career at Andson Biotech?
